AMERICAN CENTURY COMPANIES INC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 748054 KANSAS CITY, MO

Position in RXRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$953,032

-$36,604 QoQ

Shares Held

310,434

+28.3% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AMERICAN CENTURY COMPANIES INC holds $3,844,388,733 across 170 Biotechnology names. RXRX ranks #90 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,802,363	$596,347,845
2	REGN	Regeneron Pharmaceuticals, Inc.	562,097	$434,298,626
3	VRTX	Vertex Pharmaceuticals Inc / Ma	813,285	$363,164,283
4	ASND	Ascendis Pharma A/S	1,397,119	$319,563,028
5	INSM	INSMED Inc	925,799	$151,386,652
6	ARGX	Argenx SE	173,700	$126,844,425
7	IONS	Ionis Pharmaceuticals Inc	1,663,803	$124,934,967
8	CPRX	Catalyst Pharmaceuticals, Inc.	4,138,416	$102,467,180

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$953,032	310,434	+28.3%	Shares	Defined	2026-05-15
2025-12-31	$989,636	241,965	-23.5%	Shares	Defined	2026-02-13
2025-09-30	$1,542,948	316,178	+2463.5%	Shares	Defined	2025-11-12
2024-03-31	$122,969	12,334	-55.6%	Shares	Defined	2024-05-14
2023-12-31	$274,088	27,798	+172.2%	Shares	Defined	2024-02-13
2023-06-30	$76,291	10,213	-96.6%	Shares	Defined	2023-08-14
2022-03-31	$2,162,205	301,984	-0.4%	Shares	Defined	2022-05-11
2021-12-31	$5,191,263	303,051	+100.2%	Shares	Defined	2022-02-07
2021-09-30	$3,482,770	151,359	—	Shares	Defined	2021-11-10
No filing history on record for this holder in this stock.